Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Ibotta, Inc. regarding a class action lawsuit related to misleading statements about the company's contract with Kroger, which could have significant implications for investors [1][2]. Group 1: Allegations and Legal Context - The lawsuit alleges that Ibotta made false statements and failed to disclose the at-will nature of its contract with Kroger, which could allow Kroger to terminate the contract without warning [2]. - Ibotta provided detailed information about its contract with Walmart but did not adequately warn investors about the risks associated with the Kroger contract, leading to potential investor losses [2]. Group 2: Shareholder Actions and Deadlines - Shareholders who purchased Ibotta shares during the specified class period are encouraged to register for the class action, with a deadline set for June 16, 2025 [3]. - Once registered, shareholders will receive updates on the case's progress through a portfolio monitoring software, and there is no cost to participate [3]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to misleading statements or omissions by companies, emphasizing the importance of responsible business practices [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of DoubleVerify Holdings, Inc. regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during the class period from November 10, 2023, to February 27, 2025 [1][3]. Allegations - The complaint alleges that DoubleVerify's customers shifted ad spending from open exchanges to closed platforms, where the company's technological capabilities were limited, impacting its competitive position against platforms like Meta and Amazon [3]. - It is claimed that DoubleVerify's ability to monetize its Activation Services was constrained due to the high costs and time required for technology development for closed platforms, which were not adequately disclosed to investors [3]. - The lawsuit states that monetization of DoubleVerify's Activation Services on certain closed platforms would take several years, contrary to what was communicated to shareholders [3]. - Competitors of DoubleVerify were reportedly better positioned to integrate AI into their offerings on closed platforms, negatively affecting DoubleVerify's competitiveness and profitability [3]. - The company allegedly overbilled customers for ad impressions served to bots operating from known data centers, raising concerns about its billing practices [3]. - The risk disclosures provided by DoubleVerify were claimed to be materially false and misleading, as they downplayed adverse facts that had already occurred [3]. - As a result of these issues, the positive statements made by the defendants regarding the company's business and prospects were deemed materially false or misleading [3]. Next Steps for Shareholders - Shareholders who purchased shares of DoubleVerify during the specified class period are encouraged to register for the class action by July 21, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [4].

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) demand for Krispy Kreme products declined materially at McDonald's locations after the initial marketing launch; (2) demand at McDonald's locations was a driver of declining average sales per door per week; (3) the partnership with McDonald's was not profitable; (4) the foregoing posed a substantial risk to maintaining the partnership with McDon ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of DoubleVerify Holdings, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from November 10, 2023, to February 27, 2025 [1] Allegations - Allegations include that DoubleVerify's customers shifted ad spending from open exchanges to closed platforms, limiting the company's technological capabilities and competition with platforms like Meta and Amazon [1] - The complaint states that DoubleVerify's ability to monetize its Activation Services was hindered due to the high costs and time required for technology development for closed platforms [1] - It is claimed that monetization of DoubleVerify's Activation Services on certain closed platforms would take several years [1] - Competitors were reportedly better positioned to integrate AI into their offerings on closed platforms, negatively impacting DoubleVerify's competitive edge and profits [1] - The company allegedly overbilled customers for ad impressions served to declared bots operating from known data center server farms [1] - Risk disclosures from DoubleVerify were characterized as materially false and misleading, presenting adverse facts as mere possibilities [1] - As a result of these issues, the positive statements made by the defendants regarding the company's business and prospects were deemed materially false or misleading [1] Next Steps for Shareholders - Shareholders who purchased shares of DV during the specified timeframe are encouraged to register for the class action by July 21, 2025, to potentially become lead plaintiffs [2] - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case [2] About the Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit, fraud, and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3]

NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Digimarc Corporation (NASDAQ: DMRC). Shareholders who purchased shares of DMRC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/digimarc-corporation-loss-submission-form-2/?id=150972&from=3 CLASS PERIOD: M ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cerevel Therapeutics Holdings, Inc. regarding a class action lawsuit related to alleged misleading statements and omissions during a secondary stock offering, which may have artificially deflated the stock price prior to a merger announcement with AbbVie Inc. [1][4] Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes shareholders who sold or held shares during this timeframe [3]. - Shareholders are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for June 3, 2025 [5]. Group 2: Allegations Against Cerevel - The complaint alleges that Cerevel's October 16, 2023 secondary stock offering omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share [4]. - Bain Capital, Cerevel's controlling shareholder, allegedly acquired shares at an artificially depressed price while possessing nonpublic information about AbbVie's acquisition interest, leading to a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share [4]. Group 3: Legal Representation - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights and ensuring responsible business practices [6].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cerevel Therapeutics Holdings, Inc. regarding a class action lawsuit related to alleged misleading statements and omissions during a secondary stock offering, which may have artificially deflated the stock price prior to a merger announcement with AbbVie Inc. [1][4] Group 1: Class Action Details - The class period for the lawsuit is from October 11, 2023, to August 1, 2024, and includes shareholders who sold or held shares during this timeframe [3]. - Shareholders are encouraged to register for the class action by June 3, 2025, to potentially be appointed as lead plaintiffs [5]. Group 2: Allegations Against Cerevel - The complaint alleges that Cerevel's October 16, 2023 secondary stock offering documents omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share [4]. - Bain Capital, Cerevel's controlling shareholder, allegedly acquired shares at an artificially depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [4]. Group 3: Next Steps for Shareholders - Shareholders who register will be enrolled in a portfolio monitoring software to receive updates on the case's status [5]. - There is no cost or obligation for shareholders to participate in the class action [5].

Core Points - The Gross Law Firm has issued a notice to shareholders of Ibotta, Inc. regarding a class action lawsuit related to the company's initial public offering on April 18, 2024 [1][3] - The lawsuit alleges that Ibotta made false statements and failed to disclose the risks associated with its contract with Kroger, specifically that the contract was at-will and could be terminated without warning [4] - Shareholders are encouraged to register for the class action by June 16, 2025, to potentially become lead plaintiffs and receive updates on the case [5] Company and Industry Summary - Ibotta, Inc. is facing legal challenges due to allegations of misleading investors about the nature of its contract with Kroger, which could impact investor confidence and stock performance [4] - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to misleading statements from companies like Ibotta [6]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Cerevel Therapeutics Holdings, Inc. regarding a class action lawsuit related to alleged misleading statements and omissions during a secondary stock offering, which may have artificially deflated the stock price prior to a merger announcement with AbbVie Inc. [1][2] Group 1: Allegations and Impact - Cerevel's October 16, 2023 secondary stock offering documents allegedly omitted material facts about AbbVie's interest in acquiring Cerevel at a significantly higher price than the offering price of $22.81 per share, leading to an artificial deflation of Cerevel's stock price [2] - Bain Capital, Cerevel's controlling shareholder, reportedly acquired shares at this artificially depressed price while possessing nonpublic information about AbbVie's acquisition interest, resulting in a windfall of over $120 million when AbbVie agreed to acquire Cerevel for $45 per share on December 6, 2023 [2] - The January 18, 2024 Proxy statement from Cerevel is claimed to have misled investors regarding the nature and timing of AbbVie's interest in the company [2] Group 2: Class Action Details - The class period for the lawsuit includes shareholders who sold or disposed of Cerevel stock from October 11, 2023, to August 1, 2024, and those who held shares as of January 8, 2024, entitled to vote on the merger [1] - The deadline for shareholders to register for the class action and seek lead plaintiff status is June 3, 2025, with no cost or obligation to participate [3] - Registered shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's status [3]

NEW YORK, May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Krispy Kreme, Inc. (NASDAQ: DNUT).Shareholders who purchased shares of DNUT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/krispy-kreme-inc-loss-submission-form/?id=149544&from=4CLASS PERIOD: February 25, 2025 ...